Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Pincikova (Uppsala, Sweden), J. Ellingsen (Uppsala, Sweden), K. Lisspers (Uppsala, Sweden), H. Hedenström (Uppsala, Sweden), K. Bröms (Uppsala, Sweden), B. Ställberg (Uppsala, Sweden), M. Högman (Uppsala, Sweden), C. Janson (Uppsala, Sweden), A. Malinovschi (Uppsala, Sweden). The prognostic value of extended lung function characterization in COPD. 152

Member's Comments

No comment yet.

Related content which might interest you: Prognostic assessment in COPD without lung function: the B-AE-D indices Source: Eur Respir J 2016; 47:1635-1644 Year: 2016 Identification of genes with diagnostic and prognostic value in lung cancer. Source: International Congress 2019 – Biology of lung cancer Year: 2019 Simultaneous analysis of clinical markers for predicting increased lung function fluctability in stable asthma Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2012 The prognostic value of the albumin-to-fibrinogen ratio in lung cancer patients. Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019 alpha-v-beta-6 integrin may be a potential prognostic biomarker in interstitial lung disease Source: Eur Respir J 2015; 46: 486-494 Year: 2015 The prognostic role of the bronchiectasis in patients with COPD Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017 Prognostic value of modified classification based on lung function tests in idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2006; 28: Suppl. 50, 827s Year: 2006 FEV6: a useful outcome measure of lung function in COPD as assessed in a large clinical study with roflumilast Source: Eur Respir J 2004; 24: Suppl. 48, 342s Year: 2004 Time in lung cancer diagnosis and its prognostic implication Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement Year: 2018 Lung function values as predictors for outcome during non-invasive ventilation in COPD patients Source: Annual Congress 2011 - New evidence in home mechanical ventilation Year: 2011 The BODE index as a tool to predict survival in COPD lung transplant candidates Source: Eur Respir J 2010; 36: 1494-1495 Year: 2010 Predictors of lung function deterioration in COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Relevant and redundant lung function parameters in discriminating asthma from COPD Source: Eur Respir J 2005; 26: Suppl. 49, 362s Year: 2005 Lung function reversibility as a predictor of disease progression in COPD Source: International Congress 2017 – Markers of COPD progression Year: 2017 A clinical study of lung cancer cases with underlying COPD in relation to the COPD phenotype Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010 The correlation between lung sound distribution and pulmonary function in COPD patients is influenced by emphysematous lesions Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014 Predictive value of multiorgan imaging biomarkers for predicting exacerbations in COPD patients Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Analysis of surgical stage lung cancer and tumour markers prognostic value Source: Eur Respir J 2006; 28: Suppl. 50, 770s Year: 2006 Predicting IPF outcomes: lung function evaluation by %predicted and z-score Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia Year: 2021 Assessment the dependence between nutritional status and functional damage of the lungs as well as prognosis in BODE index in COPD patients Source: Annual Congress 2013 –COPD treatment Year: 2013